Search research articles
Contact Us
Filters
Showing results (51-60 of 142) with videos related to
Page
of 15
Sort By:
Biomedicines
|
October 5, 2017
Restoration of DAP Kinase Tumor Suppressor Function: A Therapeutic Strategy to Selectively Induce Apoptosis in Cancer Cells Using Immunokinase Fusion Proteins
Mehmet Kemal Tur, Adebukola K Daramola, Stefan Gattenlöhner, et al.
British Journal of Haematology
|
October 30, 2013
Human microtubule-associated protein tau mediates targeted killing of CD30(+) lymphoma cells in vitro and inhibits tumour growth in vivo
Dmitrij Hristodorov, Johannes Nordlohne, Radoslav Mladenov, et al.
Biotechnology Letters
|
April 24, 2007
Characterization of photosynthetically active duckweed (Wolffia australiana) in vitro culture by Respiration Activity Monitoring System (RAMOS)
Henrik Rechmann, Andrea Friedrich, Dara Forouzan, et al.
Chemphyschem : a European Journal of Chemical Physics and Physical Chemistry
|
March 21, 2022
Properties of Bulk In-Pt Intermetallic Compounds in Methanol Steam Reforming
Nicolas Köwitsch, Stefan Barth, Kevin Ploner, et al.
Biomaterials
|
February 18, 2014
Systematic improvement of lentivirus transduction protocols by antibody fragments fused to VSV-G as envelope glycoprotein
Ines Höfig, Stefan Barth, M Salomon, et al.
Bioconjugate Chemistry
|
May 3, 2011
Directed covalent immobilization of fluorescently labeled cytokines
Tobias Recker, Daniel Haamann, Anne Schmitt, et al.
Biomedicines
|
March 8, 2018
Updates in the Development of ImmunoRNases for the Selective Killing of Tumor Cells
Sandra Jordaan, Olusiji A Akinrinmade, Thomas Nachreiner, et al.
Journal of Cancer Research and Clinical Oncology
|
July 2, 2017
Novel PSCA targeting scFv-fusion proteins for diagnosis and immunotherapy of prostate cancer
Claudia Kessler, Alessa Pardo, Mehmet K Tur, et al.
Current Pharmaceutical Design
|
August 20, 2009
Immunokinases, a novel class of immunotherapeutics for targeted cancer therapy
Mehmet Kemal Tur, Inga Neef, Gernot Jäger, et al.
Cancer Letters
|
February 26, 2016
A novel fully-human cytolytic fusion protein based on granzyme B shows in vitro cytotoxicity and ex vivo binding to solid tumors overexpressing the epidermal growth factor receptor
Judith Niesen, Grit Hehmann-Titt, Mira Woitok, et al.
Page
of 15
Search research articles
Search
Showing results (51-60 of 142) with videos related to
Sort By:
Page
of 15
Biomedicines
|
October 5, 2017
Restoration of DAP Kinase Tumor Suppressor Function: A Therapeutic Strategy to Selectively Induce Apoptosis in Cancer Cells Using Immunokinase Fusion Proteins
Mehmet Kemal Tur, Adebukola K Daramola, Stefan Gattenlöhner, et al.
British Journal of Haematology
|
October 30, 2013
Human microtubule-associated protein tau mediates targeted killing of CD30(+) lymphoma cells in vitro and inhibits tumour growth in vivo
Dmitrij Hristodorov, Johannes Nordlohne, Radoslav Mladenov, et al.
Biotechnology Letters
|
April 24, 2007
Characterization of photosynthetically active duckweed (Wolffia australiana) in vitro culture by Respiration Activity Monitoring System (RAMOS)
Henrik Rechmann, Andrea Friedrich, Dara Forouzan, et al.
Chemphyschem : a European Journal of Chemical Physics and Physical Chemistry
|
March 21, 2022
Properties of Bulk In-Pt Intermetallic Compounds in Methanol Steam Reforming
Nicolas Köwitsch, Stefan Barth, Kevin Ploner, et al.
Biomaterials
|
February 18, 2014
Systematic improvement of lentivirus transduction protocols by antibody fragments fused to VSV-G as envelope glycoprotein
Ines Höfig, Stefan Barth, M Salomon, et al.
Bioconjugate Chemistry
|
May 3, 2011
Directed covalent immobilization of fluorescently labeled cytokines
Tobias Recker, Daniel Haamann, Anne Schmitt, et al.
Biomedicines
|
March 8, 2018
Updates in the Development of ImmunoRNases for the Selective Killing of Tumor Cells
Sandra Jordaan, Olusiji A Akinrinmade, Thomas Nachreiner, et al.
Journal of Cancer Research and Clinical Oncology
|
July 2, 2017
Novel PSCA targeting scFv-fusion proteins for diagnosis and immunotherapy of prostate cancer
Claudia Kessler, Alessa Pardo, Mehmet K Tur, et al.
Current Pharmaceutical Design
|
August 20, 2009
Immunokinases, a novel class of immunotherapeutics for targeted cancer therapy
Mehmet Kemal Tur, Inga Neef, Gernot Jäger, et al.
Cancer Letters
|
February 26, 2016
A novel fully-human cytolytic fusion protein based on granzyme B shows in vitro cytotoxicity and ex vivo binding to solid tumors overexpressing the epidermal growth factor receptor
Judith Niesen, Grit Hehmann-Titt, Mira Woitok, et al.
Page
of 15